SU2C-Ovarian Cancer Research Fund-Ovarian Cancer National Alliance-National Ovarian Cancer Coalition Translational Research Dream Team Grant
The Stand Up To Cancer-Ovarian Cancer Research Fund-Ovarian Cancer National Alliance-National Ovarian Cancer Coalition Translational Research Dream Team Grant represents a new, focused effort to implement advances in ovarian cancer research as rapidly as possible through the creation of a collaborative, translational, cancer research "Dream Team." The most talented and promising researchers across institutions will be assembled into a Dream Team, forming an optimal configuration of expertise needed to solve key problems in ovarian cancer and positively impact patients in the near future. This Dream Team will span multiple disciplines and utilize the new tools of modern biology to attack research questions in a coordinated way. Mechanisms to foster collaborations within and among the Dream Teams will be employed - an approach that promotes the sharing of information and a goal-oriented focus on measurable milestones of progress. SU2C, Ovarian Cancer Research Fund, the Ovarian Cancer National Alliance, and the National Ovarian Cancer Coalition believe that this unique Dream Team model will advance scientific research in the interests of both today's cancer patients and those who may develop cancer in the future.
The grant will provide up to $6 million in funding over a 3-year grant term, depending upon project requirements, and will be contingent on the SU2C-Ovarian Cancer Research Fund-Ovarian Cancer National Alliance-National Ovarian Cancer Coalition Joint Scientific Advisory Committee (JSAC) finding that the funds are justified and that milestones and objectives have been appropriately selected and are being satisfactorily pursued and achieved.
This grant is for a translational cancer research project that addresses critical problems in ovarian cancer patient care. The project must include therapeutic interventions for ovarian cancer, and deliver near-term patient benefit through investigation by a multidisciplinary, multi-institutional, synergistic Dream Team of expert investigators. The project must be designed to accelerate the application of therapeutic agents to the clinic (i.e., lead to patient involvement within 2-3 years from the beginning of the grant). Proposals for Dream Team research projects must present plans indicating how the work will be translated into the clinic. The ideas should be based on perceived opportunities for success as well as high-priority areas with a critical need for rapid progress beyond current medical care.
To maximize creativity, innovation, and collaboration, the Dream Team must include laboratory and clinical researchers, senior and/or young investigators, and senior scientists who have not worked together in the past.
Each Team will consist of a Dream Team Leader, a Dream Team Co-leader, no more than four additional Dream Team Principals, and at least two advocates.
The Dream Team Leader, Co-leader and Principals must have acquired a doctoral or medical degree, and must be independent investigators affiliated with an academic, medical, or research institution.